Aedifica’s agreed merger with Cofinimmo (CFMOF) will create Europe’s largest healthcare REIT and unlock significant scale and ...

Crispr investors have had a year to put aside so far, with the stock down 25%. Read more on CRSP's execution risks, high ...

The Fed left its policy rate at 4.25%-4.50% on Wednesday for a fourth straight meeting. Notable earnings this week include FDX, FDS and NKE. See more here.

Maximize your retirement with dividend income. See top strategies for reliable cash flow and let your investments work harder ...

The Precious Metals R&S Index rose 1.04% in May, while the equally weighted version gained 5.19%. See why Empress soared 36% ...

April represented one of the biggest months for trades in Jane's retirement accounts. Learn more about the retirement income ...

SoftBank’s bold AI and chip ambitions, including the $1T Arizona AI Park, bring opportunity but major funding risks and ...

FSK's 9% discount and 13.6% yield may not be attractive. See more on FSK stock's risks, dividend concerns, and portfolio ...

KSA struggles with weak momentum, high volatility, and bearish technicals, despite modest growth and a decent yield. Find out ...

FinVolution is a strong buy with robust earnings, international growth, low P/E ratio. Read my analysis of FINV stock here.

FS KKR Capital faces dividend coverage concerns and macro risks despite a high yield and solid portfolio. Find out why FSK ...

Aroundtown's high leverage and suspended dividends make it a value trap despite low valuations. See an analysis of AANNF ...